wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33418257-097B8ECA-10A4-41D9-8FFC-A018823A17B0
Q33418257-097B8ECA-10A4-41D9-8FFC-A018823A17B0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33418257-097B8ECA-10A4-41D9-8FFC-A018823A17B0
Phase 1 dose-escalation study of IV ixazomib, an investigational proteasome inhibitor, in patients with relapsed/refractory lymphoma.
P2860
Q33418257-097B8ECA-10A4-41D9-8FFC-A018823A17B0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33418257-097B8ECA-10A4-41D9-8FFC-A018823A17B0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
397ca62ed3ceb3ade33ab57d07cdef7780142570
P2860
Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma.